These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 10770342)

  • 1. Cytomegalovirus retinitis in advanced HIV-infected patients treated with protease inhibitors: incidence and outcome over 2 years.
    Labetoulle M; Goujard C; Frau E; Rogier H; Niessen F; Furlan V; Lantz O; Lecointe D; Delfraissy JF; Offret H
    J Acquir Immune Defic Syndr; 1999 Nov; 22(3):228-34. PubMed ID: 10770342
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-lasting remission of cytomegalovirus retinitis without maintenance therapy in human immunodeficiency virus-infected patients.
    Tural C; Romeu J; Sirera G; Andreu D; Conejero M; Ruiz S; Jou A; Bonjoch A; Ruiz L; Arnó A; Clotet B
    J Infect Dis; 1998 Apr; 177(4):1080-3. PubMed ID: 9534987
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Incidence and evaluation of viral retinitis in patients infected with the HIV virus and treated with HIV protease inhibitors].
    Labetoulle M; Goujard C; Frau E; Rogier H; Niessen F; Rudent A; Lantz O; Lecointe D; Furlan V; Delfraissy JF; Offret H
    J Fr Ophtalmol; 1998 Oct; 21(8):567-76. PubMed ID: 9833222
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nonprogressive CMV retinitis in AIDS patients with protease inhibitors therapy for AIDS.
    Ortega-Larrocea G; Feregrino-Goyos M
    Ocul Immunol Inflamm; 1997 Dec; 5(4):279-82. PubMed ID: 9455745
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytomegalovirus retinitis after the initiation of highly active antiretroviral therapy: a 2 year prospective study.
    Mitchell SM; Membrey WL; Youle MS; Obi A; Worrell S; Gazzard BG
    Br J Ophthalmol; 1999 Jun; 83(6):652-5. PubMed ID: 10340970
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discontinuation of maintenance therapy for cytomegalovirus retinitis in HIV-infected patients receiving highly active antiretroviral therapy.
    Jouan M; Savès M; Tubiana R; Carcelain G; Cassoux N; Aubron-Olivier C; Fillet AM; Nciri M; Sénéchal B; Chêne G; Tural C; Lasry S; Autran B; Katlama C;
    AIDS; 2001 Jan; 15(1):23-31. PubMed ID: 11192865
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytomegalovirus retinitis after initiation of highly active antiretroviral therapy.
    Jacobson MA; Zegans M; Pavan PR; O'Donnell JJ; Sattler F; Rao N; Owens S; Pollard R
    Lancet; 1997 May; 349(9063):1443-5. PubMed ID: 9164318
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High-dose (5000-microg) intravitreal ganciclovir combined with highly active antiretroviral therapy for cytomegalovirus retinitis in HIV-infected patients in Venezuela.
    Arevalo JF; Garcia RA; Mendoza AJ
    Eur J Ophthalmol; 2005; 15(5):610-8. PubMed ID: 16167292
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Incidence and risk factors for developing cytomegalovirus retinitis in HIV-infected patients receiving protease inhibitor therapy. Spanish CMV-AIDS Study Group.
    Casado JL; Arrizabalaga J; Montes M; Martí-Belda P; Tural C; Pinilla J; Gutierrez C; Portu J; Schuurman R; Aguirrebengoa K
    AIDS; 1999 Aug; 13(12):1497-502. PubMed ID: 10465073
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cessation of anti-CMV therapy in patients with CMV retinitis.
    Dunn JP
    Hopkins HIV Rep; 1998 Mar; 10(2):11. PubMed ID: 11365137
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lack of reactivation of cytomegalovirus (CMV) retinitis after stopping CMV maintenance therapy in AIDS patients with sustained elevations in CD4 T cells in response to highly active antiretroviral therapy.
    Macdonald JC; Torriani FJ; Morse LS; Karavellas MP; Reed JB; Freeman WR
    J Infect Dis; 1998 May; 177(5):1182-7. PubMed ID: 9593001
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytomegalovirus retinitis after initiation of highly active antiretroviral therapy in HIV infected patients: natural history and clinical predictors.
    Lin DY; Warren JF; Lazzeroni LC; Wolitz RA; Mansour SE
    Retina; 2002 Jun; 22(3):268-77. PubMed ID: 12055458
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improved outcome of cytomegalovirus retinitis in AIDS patients after introduction of protease inhibitors.
    Casado JL; Perez-Elías MJ; Martí-Belda P; Antela A; Suarez M; Ciancas E; Frutos B; Perez MD; Guerrero A
    J Acquir Immune Defic Syndr Hum Retrovirol; 1998 Oct; 19(2):130-4. PubMed ID: 9768621
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Control of cytomegalovirus retinitis after combination antiretroviral therapy.
    Ruhswurm I; Ries E; Krepler K; Derbolav A; Rieger A; Armbruster C; Wedrich A
    Acta Ophthalmol Scand; 1999 Aug; 77(4):471-3. PubMed ID: 10463426
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combination foscarnet and ganciclovir therapy vs monotherapy for the treatment of relapsed cytomegalovirus retinitis in patients with AIDS. The Cytomegalovirus Retreatment Trial. The Studies of Ocular Complications of AIDS Research Group in Collaboration with the AIDS Clinical Trials Group.
    Arch Ophthalmol; 1996 Jan; 114(1):23-33. PubMed ID: 8540847
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of reactivation of cytomegalovirus retinitis in patients healed after treatment with highly active antiretroviral therapy.
    Song MK; Karavellas MP; MacDonald JC; Plummer DJ; Freeman WR
    Retina; 2000; 20(2):151-5. PubMed ID: 10783947
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protease inhibitors linked to drop in CMV retinitis.
    AIDS Alert; 1997 Aug; 12(8):92-4. PubMed ID: 11364475
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Course of cytomegalovirus retinitis in the era of highly active antiretroviral therapy: 1. Retinitis progression.
    Jabs DA; Van Natta ML; Thorne JE; Weinberg DV; Meredith TA; Kuppermann BD; Sepkowitz K; Li HK;
    Ophthalmology; 2004 Dec; 111(12):2224-31. PubMed ID: 15582078
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CMVR diagnoses and progression of CD4 cell counts and HIV viral load measurements in HIV patients on HAART.
    Zambarakji HJ; Newson RB; Mitchell SM
    Br J Ophthalmol; 2001 Jul; 85(7):837-41. PubMed ID: 11423459
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Highly active antiretroviral therapy-related immune recovery in AIDS patients with cytomegalovirus retinitis.
    Macdonald JC; Karavellas MP; Torriani FJ; Morse LS; Smith IL; Reed JB; Freeman WR
    Ophthalmology; 2000 May; 107(5):877-81; discussion 881-3. PubMed ID: 10811078
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.